Welcome to CrownBio’s Blog where we share our thoughts
on the latest trends and hot stories in Oncology and CVMD

September 29, 2015 New Oral Medication Approved for Metastatic Colorectal Cancer According to the National Cancer Institute, Colorectal cancer (CRC) is the third most common non-skin cancer in men and women in the U.S. and the second leading cause of cancer-related death. In the last 10 years the number of disease-related deaths have declined, partly due to more frequent screenings. On September 22nd the U.S. FDA approved Lonsurf for ... LEARN MORE
September 22, 2015 Will Small Molecules Outperform Antibodies In Cancer Immunotherapy? A team of researchers from the Ludwig Center at Stanford University School of Medicine in California engineered a small ... LEARN MORE
September 15, 2015 Can Similarity To A Developing Egg Be The Ultimate Breaking Point Of Cancer Cells? Selectively targeting cancer cells sparing the normal organs is a major challenge in oncology drug discovery. Paramount ... LEARN MORE
September 8, 2015 An Aspirin A Day Keeps The Cancer At Bay? The American Cancer Society, in citing a study published in the Journal of the National Cancer Institute, suggests that ... LEARN MORE
September 1, 2015 The Magic of Preclinical Models in Predicting Colon Cancer Patients Response to Therapy Despite significant progress made over the last 20 years, colorectal cancer (CRC) is still a leading cause of ... LEARN MORE